State Street Corp Pharvaris N.V. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Pharvaris N.V. stock. As of the latest transaction made, State Street Corp holds 93,784 shares of PHVS stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,784
Previous 92,006
1.93%
Holding current value
$1.74 Million
Previous $1.76 Million
16.51%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PHVS
# of Institutions
50Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$140 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$82 Million78.82% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$79.8 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$68 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$61.4 Million17.41% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $628M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...